IDEA4RC FHIR Implementation Guide
0.1.0 - CI Build
150
IDEA4RC FHIR Implementation Guide
0.1.0 - CI Build
150
IDEA4RC FHIR Implementation Guide, published by IDEA4RC Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/idea4rc/ and changes regularly. See the Directory of published versions
| Draft as of 2024-11-12 |
Definitions for the Subject logical model.
Guidance on how to interpret the contents of this table can be found here
| 0. Subject | |||||||
| Definition | Subject of care Maturity Level: 0 Draft | ||||||
| Short | Subject of care | ||||||
| Logical Model | Instances of this logical model are not marked to be the target of a Reference | ||||||
| 2. Subject.sex | |||||||
| Definition | Describes biological sex as recorded in the patient's identity document or in the hospital record. In the absence of documentation, the one declared by the patient will be recorded | ||||||
| Short | Gender | ||||||
| Comments | Male; Female; Unknown. Male - 8507 Female - 8532 Unknown - 4129922 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 4. Subject.race | |||||||
| Definition | Describes race as recorded in the hospital record, the one declared by the patient,, otherwise, the onerecognized by the observer | ||||||
| Short | Race | ||||||
| Comments | Unknown; White; Black; Asians/Pacific Islanders; American Indian/Alaska Native White - 8527 Black - 8516 Asian/Pacific Islanders - 8515 American Indian/Alaska Native - 8657 Unknown - 4129922 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 6. Subject.birthYear | |||||||
| Definition | Year of birth of the patient. | ||||||
| Short | Birth year | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 8. Subject.countryOfResidence | |||||||
| Definition | Country of residence at the time of diagnosis | ||||||
| Short | Country of Residence | ||||||
| Comments | Value from the code list of countries Son in the hierarchy of countries | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 10. Subject.smoking | |||||||
| Definition | Describes tobacco smoker habits within the options proposed | ||||||
| Short | Smoking | ||||||
| Comments | Current tobacco smoker; Former smoker (at least for 12 months); Never smoker; Unknown Current smoker - 36309332 Former smoker - 45883458 Never smoker - 45879404 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 12. Subject.cigarettesPackYearsSmokedDuringLife | |||||||
| Definition | The amount of cigarette pack smoked during life | ||||||
| Short | Cigarettes pack years smoked during life | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 14. Subject.alcohol | |||||||
| Definition | Describes alcohol habits within the options proposed | ||||||
| Short | Alcohol | ||||||
| Comments | Current; Former (at least for 12 months); Never; History of alcohol dependence; Unknown Current drinker - 4074035 Ex-drinker - 4220362 Lifetime non-drinker of alcohol - 37204556 Ex-problem drinker - 4117706 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 16. Subject.bMI | |||||||
| Definition | Body Mass Index information if weight and height are included. it is calculated as BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in metres squared. | ||||||
| Short | Height/weight (BMI) | ||||||
| Control | 0..1 | ||||||
| Type | Quantity | ||||||
| Obligations |
| ||||||
| 18. Subject.charlsonComorbidityIndex | |||||||
| Definition | Provides the Charlson Comorbidity index for the patient | ||||||
| Short | Charlson Comorbidity index | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 20. Subject.comorbidity | |||||||
| Definition | Describes whether the patient was diagnosed before treatment of at least one of the comorbidities listed next (or not) relevant for head and neck cancer. | ||||||
| Short | Comorbidity | ||||||
| Comments | Yes; No; Unknown Yes - 4188539 No - 4188540 Unknown - 4129922 | ||||||
| Control | 1..1 | ||||||
| Type | BackboneElement | ||||||
| Obligations |
| ||||||
| 22. Subject.comorbidity.myocardialInfarction | |||||||
| Definition | Describes comorbidities reported or assesed before treatment. More than one choice is allowed. Please do not include the current cancer in this calculation, only the previous cancer. | ||||||
| Short | Myocardial infarction | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 24. Subject.comorbidity.congestiveHeartFailure | |||||||
| Definition | Previous cancer comorbidity related to Congestive heart failure | ||||||
| Short | Congestive heart failure | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 26. Subject.comorbidity.peripheralVascularDisease | |||||||
| Definition | Previous cancer comorbidity related to Peripheral vascular disease | ||||||
| Short | Peripheral vascular disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 28. Subject.comorbidity.cerebrovascularAccidentExceptHemiplegia | |||||||
| Definition | Previous cancer comorbidity related to Cerebrovascular accident (except hemiplegia) | ||||||
| Short | Cerebrovascular accident (except hemiplegia) | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 30. Subject.comorbidity.dementia | |||||||
| Definition | Previous cancer comorbidity related to Dementia | ||||||
| Short | Dementia | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 32. Subject.comorbidity.chronicPulmonaryDisease | |||||||
| Definition | Previous cancer comorbidity related to Chronic pulmonary disease | ||||||
| Short | Chronic pulmonary disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 34. Subject.comorbidity.connectiveTissueDisease | |||||||
| Definition | Previous cancer comorbidity related to Connective tissue disease | ||||||
| Short | Connective tissue disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 36. Subject.comorbidity.ulcer | |||||||
| Definition | Previous cancer comorbidity related to Ulcer | ||||||
| Short | Ulcer | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 38. Subject.comorbidity.mildLiverDisease | |||||||
| Definition | Previous cancer comorbidity related to Mild liver disease | ||||||
| Short | Mild liver disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 40. Subject.comorbidity.moderateToSevereLiverDisease | |||||||
| Definition | Previous cancer comorbidity related to Moderate to severe liver disease | ||||||
| Short | Moderate to severe liver disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 42. Subject.comorbidity.diabetes | |||||||
| Definition | Previous cancer comorbidity related to Diabetes (without complications) | ||||||
| Short | Diabetes (without complications) | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 44. Subject.comorbidity.diabetesWithEndOrganDamage | |||||||
| Definition | Previous cancer comorbidity related to Diabetes with end organ damage | ||||||
| Short | Diabetes with end organ damage | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 46. Subject.comorbidity.hemiplegia | |||||||
| Definition | Previous cancer comorbidity related to Hemiplegia | ||||||
| Short | Hemiplegia | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 48. Subject.comorbidity.moderateToSevereRenalDisease | |||||||
| Definition | Previous cancer comorbidity related to Moderate to severe renal disease | ||||||
| Short | Moderate to severe renal disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 50. Subject.comorbidity.solidTumor | |||||||
| Definition | Previous cancer comorbidity related to Solid tumor (non metastatic) | ||||||
| Short | Solid tumor (non metastatic) | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 52. Subject.comorbidity.metastaticSolidTumor | |||||||
| Definition | Previous cancer comorbidity related to Metastatic solid tumor | ||||||
| Short | Metastatic solid tumor | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 54. Subject.comorbidity.leukemia | |||||||
| Definition | Previous cancer comorbidity related to Leukemia | ||||||
| Short | Leukemia | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 56. Subject.comorbidity.lymphoma | |||||||
| Definition | Previous cancer comorbidity related to Lymphoma | ||||||
| Short | Lymphoma | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 58. Subject.comorbidity.multipleMyeloma | |||||||
| Definition | Previous cancer comorbidity related to Multiple myeloma | ||||||
| Short | Multiple myeloma | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 60. Subject.comorbidity.aids | |||||||
| Definition | Previous cancer comorbidity related to AIDS | ||||||
| Short | AIDS | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 62. Subject.ecogPsAtDiagnosis | |||||||
| Definition | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis | ||||||
| Short | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis | ||||||
| Comments | Ecog grades 0-5 | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 64. Subject.ecogPsLabel | |||||||
| Definition | Eastern Cooperative Oncology Group performance status (ECOG PS) label | ||||||
| Short | ECOG PS label | ||||||
| Comments | Ecog grades 0-5 ECOG performance status grade 0 - 4175026 ECOG performance status grade 1 - 4173614 ECOG performance status grade 2 - 4172043 ECOG performance status grade 3 - 4174241 ECOG performance status grade 4 - 4174251 ECOG performance status grade 5 - 4173456 | ||||||
| Control | 0..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 66. Subject.karnofsyIndexAtDiagnosis | |||||||
| Definition | Karnofsy index at diagnosis | ||||||
| Short | Karnofsy index at diagnosis | ||||||
| Comments | KPS Scale | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 68. Subject.karnofsyIndexLabel | |||||||
| Definition | Karnofsy index at diagnosis | ||||||
| Short | Karnofsy index label | ||||||
| Comments | KPS Scale SONS Functional Neurologic Status - Karnofsky Performance Scale (KPS) - 35917688 | ||||||
| Control | 0..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 70. Subject.noGeneticSyndromeWho2020 | |||||||
| Definition | Describes whether the patient was diagnosed before treatment of at least one of the diseases, syndromes listed next (or not) relevant for sarcoma. | ||||||
| Short | No Genetic syndrome WHO 2020 | ||||||
| Control | 1..1 | ||||||
| Type | BackboneElement | ||||||
| Obligations |
| ||||||
| 72. Subject.noGeneticSyndromeWho2020.olliersDisease | |||||||
| Definition | Olliers disease | ||||||
| Short | Olliers disease | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 74. Subject.noGeneticSyndromeWho2020.maffuciSyndrome | |||||||
| Definition | Maffuci syndrome | ||||||
| Short | Maffuci syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 76. Subject.noGeneticSyndromeWho2020.liFraumeniSyndrome | |||||||
| Definition | Li-Fraumeni syndrome | ||||||
| Short | Li-Fraumeni syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 78. Subject.noGeneticSyndromeWho2020.mcCuneAlbrightSyndrome | |||||||
| Definition | McCune-Albright syndrome | ||||||
| Short | McCune-Albright syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 80. Subject.noGeneticSyndromeWho2020.multipleOsteochondromas | |||||||
| Definition | Multiple osteochondromas | ||||||
| Short | Multiple osteochondromas | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 82. Subject.noGeneticSyndromeWho2020.neurofibromatosisType1 | |||||||
| Definition | Neurofibromatosis type 2 | ||||||
| Short | Neurofibromatosis type 1 | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 84. Subject.noGeneticSyndromeWho2020.rothmundThomsonSyndrome | |||||||
| Definition | Rothmund-Thomson syndrome | ||||||
| Short | Rothmund-Thomson syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 86. Subject.noGeneticSyndromeWho2020.wernerSyndrome | |||||||
| Definition | Werner syndrome | ||||||
| Short | Werner syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 88. Subject.noGeneticSyndromeWho2020.retinoblastoma | |||||||
| Definition | Retinoblastoma | ||||||
| Short | Retinoblastoma | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 90. Subject.noGeneticSyndromeWho2020.pagetDisease | |||||||
| Definition | Paget disease | ||||||
| Short | Paget disease | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 92. Subject.noGeneticSyndromeWho2020.otherSyndromes | |||||||
| Definition | Other Genetic syndrome WHO 2020 | ||||||
| Short | Other Genetic syndrome WHO 2020 | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 94. Subject.occurrenceOfOtherCancer | |||||||
| Definition | Occurrence of other cancer | ||||||
| Short | Occurrence of other cancer | ||||||
| Comments | Children (and subchildren) of Neoplasm and/or hamartoma - 4266186 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 96. Subject.previousCancerTreatment | |||||||
| Definition | Previous cancer treatment | ||||||
| Short | Previous cancer treatment | ||||||
| Comments | Chemotherapy - 4273629 Radiation oncology- 4170755 Surgery - 4121697 Comprehensive medication therapy review - 42535584 Immunological therapy - 4295112 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
Guidance on how to interpret the contents of this table can be found here
| 0. Subject | |||||||
| Definition | Subject of care Maturity Level: 0 Draft | ||||||
| Short | Subject of care | ||||||
| Control | 0..* | ||||||
| Is Modifier | false | ||||||
| Logical Model | Instances of this logical model are not marked to be the target of a Reference | ||||||
| 2. Subject.sex | |||||||
| Definition | Describes biological sex as recorded in the patient's identity document or in the hospital record. In the absence of documentation, the one declared by the patient will be recorded | ||||||
| Short | Gender | ||||||
| Comments | Male; Female; Unknown. Male - 8507 Female - 8532 Unknown - 4129922 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 4. Subject.race | |||||||
| Definition | Describes race as recorded in the hospital record, the one declared by the patient,, otherwise, the onerecognized by the observer | ||||||
| Short | Race | ||||||
| Comments | Unknown; White; Black; Asians/Pacific Islanders; American Indian/Alaska Native White - 8527 Black - 8516 Asian/Pacific Islanders - 8515 American Indian/Alaska Native - 8657 Unknown - 4129922 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 6. Subject.birthYear | |||||||
| Definition | Year of birth of the patient. | ||||||
| Short | Birth year | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 8. Subject.countryOfResidence | |||||||
| Definition | Country of residence at the time of diagnosis | ||||||
| Short | Country of Residence | ||||||
| Comments | Value from the code list of countries Son in the hierarchy of countries | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 10. Subject.smoking | |||||||
| Definition | Describes tobacco smoker habits within the options proposed | ||||||
| Short | Smoking | ||||||
| Comments | Current tobacco smoker; Former smoker (at least for 12 months); Never smoker; Unknown Current smoker - 36309332 Former smoker - 45883458 Never smoker - 45879404 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 12. Subject.cigarettesPackYearsSmokedDuringLife | |||||||
| Definition | The amount of cigarette pack smoked during life | ||||||
| Short | Cigarettes pack years smoked during life | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 14. Subject.alcohol | |||||||
| Definition | Describes alcohol habits within the options proposed | ||||||
| Short | Alcohol | ||||||
| Comments | Current; Former (at least for 12 months); Never; History of alcohol dependence; Unknown Current drinker - 4074035 Ex-drinker - 4220362 Lifetime non-drinker of alcohol - 37204556 Ex-problem drinker - 4117706 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 16. Subject.bMI | |||||||
| Definition | Body Mass Index information if weight and height are included. it is calculated as BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in metres squared. | ||||||
| Short | Height/weight (BMI) | ||||||
| Control | 0..1 | ||||||
| Type | Quantity | ||||||
| Obligations |
| ||||||
| 18. Subject.charlsonComorbidityIndex | |||||||
| Definition | Provides the Charlson Comorbidity index for the patient | ||||||
| Short | Charlson Comorbidity index | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 20. Subject.comorbidity | |||||||
| Definition | Describes whether the patient was diagnosed before treatment of at least one of the comorbidities listed next (or not) relevant for head and neck cancer. | ||||||
| Short | Comorbidity | ||||||
| Comments | Yes; No; Unknown Yes - 4188539 No - 4188540 Unknown - 4129922 | ||||||
| Control | 1..1 | ||||||
| Type | BackboneElement | ||||||
| Obligations |
| ||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) | ||||||
| 22. Subject.comorbidity.modifierExtension | |||||||
| Definition | May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). | ||||||
| Short | Extensions that cannot be ignored even if unrecognized | ||||||
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. | ||||||
| Control | 0..* | ||||||
| Type | Extension | ||||||
| Is Modifier | true because Modifier extensions are expected to modify the meaning or interpretation of the element that contains them | ||||||
| Summary | true | ||||||
| Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. | ||||||
| Alternate Names | extensions, user content, modifiers | ||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) ext-1: Must have either extensions or value[x], not both (extension.exists() != value.exists()) | ||||||
| 24. Subject.comorbidity.myocardialInfarction | |||||||
| Definition | Describes comorbidities reported or assesed before treatment. More than one choice is allowed. Please do not include the current cancer in this calculation, only the previous cancer. | ||||||
| Short | Myocardial infarction | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 26. Subject.comorbidity.congestiveHeartFailure | |||||||
| Definition | Previous cancer comorbidity related to Congestive heart failure | ||||||
| Short | Congestive heart failure | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 28. Subject.comorbidity.peripheralVascularDisease | |||||||
| Definition | Previous cancer comorbidity related to Peripheral vascular disease | ||||||
| Short | Peripheral vascular disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 30. Subject.comorbidity.cerebrovascularAccidentExceptHemiplegia | |||||||
| Definition | Previous cancer comorbidity related to Cerebrovascular accident (except hemiplegia) | ||||||
| Short | Cerebrovascular accident (except hemiplegia) | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 32. Subject.comorbidity.dementia | |||||||
| Definition | Previous cancer comorbidity related to Dementia | ||||||
| Short | Dementia | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 34. Subject.comorbidity.chronicPulmonaryDisease | |||||||
| Definition | Previous cancer comorbidity related to Chronic pulmonary disease | ||||||
| Short | Chronic pulmonary disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 36. Subject.comorbidity.connectiveTissueDisease | |||||||
| Definition | Previous cancer comorbidity related to Connective tissue disease | ||||||
| Short | Connective tissue disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 38. Subject.comorbidity.ulcer | |||||||
| Definition | Previous cancer comorbidity related to Ulcer | ||||||
| Short | Ulcer | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 40. Subject.comorbidity.mildLiverDisease | |||||||
| Definition | Previous cancer comorbidity related to Mild liver disease | ||||||
| Short | Mild liver disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 42. Subject.comorbidity.moderateToSevereLiverDisease | |||||||
| Definition | Previous cancer comorbidity related to Moderate to severe liver disease | ||||||
| Short | Moderate to severe liver disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 44. Subject.comorbidity.diabetes | |||||||
| Definition | Previous cancer comorbidity related to Diabetes (without complications) | ||||||
| Short | Diabetes (without complications) | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 46. Subject.comorbidity.diabetesWithEndOrganDamage | |||||||
| Definition | Previous cancer comorbidity related to Diabetes with end organ damage | ||||||
| Short | Diabetes with end organ damage | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 48. Subject.comorbidity.hemiplegia | |||||||
| Definition | Previous cancer comorbidity related to Hemiplegia | ||||||
| Short | Hemiplegia | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 50. Subject.comorbidity.moderateToSevereRenalDisease | |||||||
| Definition | Previous cancer comorbidity related to Moderate to severe renal disease | ||||||
| Short | Moderate to severe renal disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 52. Subject.comorbidity.solidTumor | |||||||
| Definition | Previous cancer comorbidity related to Solid tumor (non metastatic) | ||||||
| Short | Solid tumor (non metastatic) | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 54. Subject.comorbidity.metastaticSolidTumor | |||||||
| Definition | Previous cancer comorbidity related to Metastatic solid tumor | ||||||
| Short | Metastatic solid tumor | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 56. Subject.comorbidity.leukemia | |||||||
| Definition | Previous cancer comorbidity related to Leukemia | ||||||
| Short | Leukemia | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 58. Subject.comorbidity.lymphoma | |||||||
| Definition | Previous cancer comorbidity related to Lymphoma | ||||||
| Short | Lymphoma | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 60. Subject.comorbidity.multipleMyeloma | |||||||
| Definition | Previous cancer comorbidity related to Multiple myeloma | ||||||
| Short | Multiple myeloma | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 62. Subject.comorbidity.aids | |||||||
| Definition | Previous cancer comorbidity related to AIDS | ||||||
| Short | AIDS | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 64. Subject.ecogPsAtDiagnosis | |||||||
| Definition | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis | ||||||
| Short | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis | ||||||
| Comments | Ecog grades 0-5 | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 66. Subject.ecogPsLabel | |||||||
| Definition | Eastern Cooperative Oncology Group performance status (ECOG PS) label | ||||||
| Short | ECOG PS label | ||||||
| Comments | Ecog grades 0-5 ECOG performance status grade 0 - 4175026 ECOG performance status grade 1 - 4173614 ECOG performance status grade 2 - 4172043 ECOG performance status grade 3 - 4174241 ECOG performance status grade 4 - 4174251 ECOG performance status grade 5 - 4173456 | ||||||
| Control | 0..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 68. Subject.karnofsyIndexAtDiagnosis | |||||||
| Definition | Karnofsy index at diagnosis | ||||||
| Short | Karnofsy index at diagnosis | ||||||
| Comments | KPS Scale | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 70. Subject.karnofsyIndexLabel | |||||||
| Definition | Karnofsy index at diagnosis | ||||||
| Short | Karnofsy index label | ||||||
| Comments | KPS Scale SONS Functional Neurologic Status - Karnofsky Performance Scale (KPS) - 35917688 | ||||||
| Control | 0..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 72. Subject.noGeneticSyndromeWho2020 | |||||||
| Definition | Describes whether the patient was diagnosed before treatment of at least one of the diseases, syndromes listed next (or not) relevant for sarcoma. | ||||||
| Short | No Genetic syndrome WHO 2020 | ||||||
| Control | 1..1 | ||||||
| Type | BackboneElement | ||||||
| Obligations |
| ||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) | ||||||
| 74. Subject.noGeneticSyndromeWho2020.modifierExtension | |||||||
| Definition | May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). | ||||||
| Short | Extensions that cannot be ignored even if unrecognized | ||||||
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. | ||||||
| Control | 0..* | ||||||
| Type | Extension | ||||||
| Is Modifier | true because Modifier extensions are expected to modify the meaning or interpretation of the element that contains them | ||||||
| Summary | true | ||||||
| Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. | ||||||
| Alternate Names | extensions, user content, modifiers | ||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) ext-1: Must have either extensions or value[x], not both (extension.exists() != value.exists()) | ||||||
| 76. Subject.noGeneticSyndromeWho2020.olliersDisease | |||||||
| Definition | Olliers disease | ||||||
| Short | Olliers disease | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 78. Subject.noGeneticSyndromeWho2020.maffuciSyndrome | |||||||
| Definition | Maffuci syndrome | ||||||
| Short | Maffuci syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 80. Subject.noGeneticSyndromeWho2020.liFraumeniSyndrome | |||||||
| Definition | Li-Fraumeni syndrome | ||||||
| Short | Li-Fraumeni syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 82. Subject.noGeneticSyndromeWho2020.mcCuneAlbrightSyndrome | |||||||
| Definition | McCune-Albright syndrome | ||||||
| Short | McCune-Albright syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 84. Subject.noGeneticSyndromeWho2020.multipleOsteochondromas | |||||||
| Definition | Multiple osteochondromas | ||||||
| Short | Multiple osteochondromas | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 86. Subject.noGeneticSyndromeWho2020.neurofibromatosisType1 | |||||||
| Definition | Neurofibromatosis type 2 | ||||||
| Short | Neurofibromatosis type 1 | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 88. Subject.noGeneticSyndromeWho2020.rothmundThomsonSyndrome | |||||||
| Definition | Rothmund-Thomson syndrome | ||||||
| Short | Rothmund-Thomson syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 90. Subject.noGeneticSyndromeWho2020.wernerSyndrome | |||||||
| Definition | Werner syndrome | ||||||
| Short | Werner syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 92. Subject.noGeneticSyndromeWho2020.retinoblastoma | |||||||
| Definition | Retinoblastoma | ||||||
| Short | Retinoblastoma | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 94. Subject.noGeneticSyndromeWho2020.pagetDisease | |||||||
| Definition | Paget disease | ||||||
| Short | Paget disease | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 96. Subject.noGeneticSyndromeWho2020.otherSyndromes | |||||||
| Definition | Other Genetic syndrome WHO 2020 | ||||||
| Short | Other Genetic syndrome WHO 2020 | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 98. Subject.occurrenceOfOtherCancer | |||||||
| Definition | Occurrence of other cancer | ||||||
| Short | Occurrence of other cancer | ||||||
| Comments | Children (and subchildren) of Neoplasm and/or hamartoma - 4266186 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 100. Subject.previousCancerTreatment | |||||||
| Definition | Previous cancer treatment | ||||||
| Short | Previous cancer treatment | ||||||
| Comments | Chemotherapy - 4273629 Radiation oncology- 4170755 Surgery - 4121697 Comprehensive medication therapy review - 42535584 Immunological therapy - 4295112 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
Guidance on how to interpret the contents of this table can be found here
| 0. Subject | |||||||
| Definition | Subject of care Maturity Level: 0 Draft | ||||||
| Short | Subject of care | ||||||
| Control | 0..* | ||||||
| Is Modifier | false | ||||||
| Logical Model | Instances of this logical model are not marked to be the target of a Reference | ||||||
| 2. Subject.sex | |||||||
| Definition | Describes biological sex as recorded in the patient's identity document or in the hospital record. In the absence of documentation, the one declared by the patient will be recorded | ||||||
| Short | Gender | ||||||
| Comments | Male; Female; Unknown. Male - 8507 Female - 8532 Unknown - 4129922 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 4. Subject.race | |||||||
| Definition | Describes race as recorded in the hospital record, the one declared by the patient,, otherwise, the onerecognized by the observer | ||||||
| Short | Race | ||||||
| Comments | Unknown; White; Black; Asians/Pacific Islanders; American Indian/Alaska Native White - 8527 Black - 8516 Asian/Pacific Islanders - 8515 American Indian/Alaska Native - 8657 Unknown - 4129922 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 6. Subject.birthYear | |||||||
| Definition | Year of birth of the patient. | ||||||
| Short | Birth year | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 8. Subject.countryOfResidence | |||||||
| Definition | Country of residence at the time of diagnosis | ||||||
| Short | Country of Residence | ||||||
| Comments | Value from the code list of countries Son in the hierarchy of countries | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 10. Subject.smoking | |||||||
| Definition | Describes tobacco smoker habits within the options proposed | ||||||
| Short | Smoking | ||||||
| Comments | Current tobacco smoker; Former smoker (at least for 12 months); Never smoker; Unknown Current smoker - 36309332 Former smoker - 45883458 Never smoker - 45879404 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 12. Subject.cigarettesPackYearsSmokedDuringLife | |||||||
| Definition | The amount of cigarette pack smoked during life | ||||||
| Short | Cigarettes pack years smoked during life | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 14. Subject.alcohol | |||||||
| Definition | Describes alcohol habits within the options proposed | ||||||
| Short | Alcohol | ||||||
| Comments | Current; Former (at least for 12 months); Never; History of alcohol dependence; Unknown Current drinker - 4074035 Ex-drinker - 4220362 Lifetime non-drinker of alcohol - 37204556 Ex-problem drinker - 4117706 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 16. Subject.bMI | |||||||
| Definition | Body Mass Index information if weight and height are included. it is calculated as BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in metres squared. | ||||||
| Short | Height/weight (BMI) | ||||||
| Control | 0..1 | ||||||
| Type | Quantity | ||||||
| Obligations |
| ||||||
| 18. Subject.charlsonComorbidityIndex | |||||||
| Definition | Provides the Charlson Comorbidity index for the patient | ||||||
| Short | Charlson Comorbidity index | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 20. Subject.comorbidity | |||||||
| Definition | Describes whether the patient was diagnosed before treatment of at least one of the comorbidities listed next (or not) relevant for head and neck cancer. | ||||||
| Short | Comorbidity | ||||||
| Comments | Yes; No; Unknown Yes - 4188539 No - 4188540 Unknown - 4129922 | ||||||
| Control | 1..1 | ||||||
| Type | BackboneElement | ||||||
| Obligations |
| ||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) | ||||||
| 22. Subject.comorbidity.id | |||||||
| Definition | Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces. | ||||||
| Short | Unique id for inter-element referencing | ||||||
| Control | 0..1 | ||||||
| Type | string | ||||||
| Is Modifier | false | ||||||
| XML Format | In the XML format, this property is represented as an attribute. | ||||||
| Summary | false | ||||||
| 24. Subject.comorbidity.extension | |||||||
| Definition | May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. | ||||||
| Short | Additional content defined by implementations | ||||||
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. | ||||||
| Control | 0..* | ||||||
| Type | Extension | ||||||
| Is Modifier | false | ||||||
| Summary | false | ||||||
| Alternate Names | extensions, user content | ||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count()))ext-1: Must have either extensions or value[x], not both ( extension.exists() != value.exists()) | ||||||
| Slicing | This element introduces a set of slices on Subject.comorbidity.extension. The slices areUnordered and Open, and can be differentiated using the following discriminators: | ||||||
| 26. Subject.comorbidity.modifierExtension | |||||||
| Definition | May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). | ||||||
| Short | Extensions that cannot be ignored even if unrecognized | ||||||
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. | ||||||
| Control | 0..* | ||||||
| Type | Extension | ||||||
| Is Modifier | true because Modifier extensions are expected to modify the meaning or interpretation of the element that contains them | ||||||
| Summary | true | ||||||
| Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. | ||||||
| Alternate Names | extensions, user content, modifiers | ||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count()))ext-1: Must have either extensions or value[x], not both ( extension.exists() != value.exists()) | ||||||
| 28. Subject.comorbidity.myocardialInfarction | |||||||
| Definition | Describes comorbidities reported or assesed before treatment. More than one choice is allowed. Please do not include the current cancer in this calculation, only the previous cancer. | ||||||
| Short | Myocardial infarction | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 30. Subject.comorbidity.congestiveHeartFailure | |||||||
| Definition | Previous cancer comorbidity related to Congestive heart failure | ||||||
| Short | Congestive heart failure | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 32. Subject.comorbidity.peripheralVascularDisease | |||||||
| Definition | Previous cancer comorbidity related to Peripheral vascular disease | ||||||
| Short | Peripheral vascular disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 34. Subject.comorbidity.cerebrovascularAccidentExceptHemiplegia | |||||||
| Definition | Previous cancer comorbidity related to Cerebrovascular accident (except hemiplegia) | ||||||
| Short | Cerebrovascular accident (except hemiplegia) | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 36. Subject.comorbidity.dementia | |||||||
| Definition | Previous cancer comorbidity related to Dementia | ||||||
| Short | Dementia | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 38. Subject.comorbidity.chronicPulmonaryDisease | |||||||
| Definition | Previous cancer comorbidity related to Chronic pulmonary disease | ||||||
| Short | Chronic pulmonary disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 40. Subject.comorbidity.connectiveTissueDisease | |||||||
| Definition | Previous cancer comorbidity related to Connective tissue disease | ||||||
| Short | Connective tissue disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 42. Subject.comorbidity.ulcer | |||||||
| Definition | Previous cancer comorbidity related to Ulcer | ||||||
| Short | Ulcer | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 44. Subject.comorbidity.mildLiverDisease | |||||||
| Definition | Previous cancer comorbidity related to Mild liver disease | ||||||
| Short | Mild liver disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 46. Subject.comorbidity.moderateToSevereLiverDisease | |||||||
| Definition | Previous cancer comorbidity related to Moderate to severe liver disease | ||||||
| Short | Moderate to severe liver disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 48. Subject.comorbidity.diabetes | |||||||
| Definition | Previous cancer comorbidity related to Diabetes (without complications) | ||||||
| Short | Diabetes (without complications) | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 50. Subject.comorbidity.diabetesWithEndOrganDamage | |||||||
| Definition | Previous cancer comorbidity related to Diabetes with end organ damage | ||||||
| Short | Diabetes with end organ damage | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 52. Subject.comorbidity.hemiplegia | |||||||
| Definition | Previous cancer comorbidity related to Hemiplegia | ||||||
| Short | Hemiplegia | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 54. Subject.comorbidity.moderateToSevereRenalDisease | |||||||
| Definition | Previous cancer comorbidity related to Moderate to severe renal disease | ||||||
| Short | Moderate to severe renal disease | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 56. Subject.comorbidity.solidTumor | |||||||
| Definition | Previous cancer comorbidity related to Solid tumor (non metastatic) | ||||||
| Short | Solid tumor (non metastatic) | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 58. Subject.comorbidity.metastaticSolidTumor | |||||||
| Definition | Previous cancer comorbidity related to Metastatic solid tumor | ||||||
| Short | Metastatic solid tumor | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 60. Subject.comorbidity.leukemia | |||||||
| Definition | Previous cancer comorbidity related to Leukemia | ||||||
| Short | Leukemia | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 62. Subject.comorbidity.lymphoma | |||||||
| Definition | Previous cancer comorbidity related to Lymphoma | ||||||
| Short | Lymphoma | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 64. Subject.comorbidity.multipleMyeloma | |||||||
| Definition | Previous cancer comorbidity related to Multiple myeloma | ||||||
| Short | Multiple myeloma | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 66. Subject.comorbidity.aids | |||||||
| Definition | Previous cancer comorbidity related to AIDS | ||||||
| Short | AIDS | ||||||
| Control | 0..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 68. Subject.ecogPsAtDiagnosis | |||||||
| Definition | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis | ||||||
| Short | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis | ||||||
| Comments | Ecog grades 0-5 | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 70. Subject.ecogPsLabel | |||||||
| Definition | Eastern Cooperative Oncology Group performance status (ECOG PS) label | ||||||
| Short | ECOG PS label | ||||||
| Comments | Ecog grades 0-5 ECOG performance status grade 0 - 4175026 ECOG performance status grade 1 - 4173614 ECOG performance status grade 2 - 4172043 ECOG performance status grade 3 - 4174241 ECOG performance status grade 4 - 4174251 ECOG performance status grade 5 - 4173456 | ||||||
| Control | 0..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 72. Subject.karnofsyIndexAtDiagnosis | |||||||
| Definition | Karnofsy index at diagnosis | ||||||
| Short | Karnofsy index at diagnosis | ||||||
| Comments | KPS Scale | ||||||
| Control | 0..1 | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 74. Subject.karnofsyIndexLabel | |||||||
| Definition | Karnofsy index at diagnosis | ||||||
| Short | Karnofsy index label | ||||||
| Comments | KPS Scale SONS Functional Neurologic Status - Karnofsky Performance Scale (KPS) - 35917688 | ||||||
| Control | 0..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 76. Subject.noGeneticSyndromeWho2020 | |||||||
| Definition | Describes whether the patient was diagnosed before treatment of at least one of the diseases, syndromes listed next (or not) relevant for sarcoma. | ||||||
| Short | No Genetic syndrome WHO 2020 | ||||||
| Control | 1..1 | ||||||
| Type | BackboneElement | ||||||
| Obligations |
| ||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) | ||||||
| 78. Subject.noGeneticSyndromeWho2020.id | |||||||
| Definition | Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces. | ||||||
| Short | Unique id for inter-element referencing | ||||||
| Control | 0..1 | ||||||
| Type | string | ||||||
| Is Modifier | false | ||||||
| XML Format | In the XML format, this property is represented as an attribute. | ||||||
| Summary | false | ||||||
| 80. Subject.noGeneticSyndromeWho2020.extension | |||||||
| Definition | May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. | ||||||
| Short | Additional content defined by implementations | ||||||
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. | ||||||
| Control | 0..* | ||||||
| Type | Extension | ||||||
| Is Modifier | false | ||||||
| Summary | false | ||||||
| Alternate Names | extensions, user content | ||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count()))ext-1: Must have either extensions or value[x], not both ( extension.exists() != value.exists()) | ||||||
| Slicing | This element introduces a set of slices on Subject.noGeneticSyndromeWho2020.extension. The slices areUnordered and Open, and can be differentiated using the following discriminators: | ||||||
| 82. Subject.noGeneticSyndromeWho2020.modifierExtension | |||||||
| Definition | May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). | ||||||
| Short | Extensions that cannot be ignored even if unrecognized | ||||||
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. | ||||||
| Control | 0..* | ||||||
| Type | Extension | ||||||
| Is Modifier | true because Modifier extensions are expected to modify the meaning or interpretation of the element that contains them | ||||||
| Summary | true | ||||||
| Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. | ||||||
| Alternate Names | extensions, user content, modifiers | ||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count()))ext-1: Must have either extensions or value[x], not both ( extension.exists() != value.exists()) | ||||||
| 84. Subject.noGeneticSyndromeWho2020.olliersDisease | |||||||
| Definition | Olliers disease | ||||||
| Short | Olliers disease | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 86. Subject.noGeneticSyndromeWho2020.maffuciSyndrome | |||||||
| Definition | Maffuci syndrome | ||||||
| Short | Maffuci syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 88. Subject.noGeneticSyndromeWho2020.liFraumeniSyndrome | |||||||
| Definition | Li-Fraumeni syndrome | ||||||
| Short | Li-Fraumeni syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 90. Subject.noGeneticSyndromeWho2020.mcCuneAlbrightSyndrome | |||||||
| Definition | McCune-Albright syndrome | ||||||
| Short | McCune-Albright syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 92. Subject.noGeneticSyndromeWho2020.multipleOsteochondromas | |||||||
| Definition | Multiple osteochondromas | ||||||
| Short | Multiple osteochondromas | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 94. Subject.noGeneticSyndromeWho2020.neurofibromatosisType1 | |||||||
| Definition | Neurofibromatosis type 2 | ||||||
| Short | Neurofibromatosis type 1 | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 96. Subject.noGeneticSyndromeWho2020.rothmundThomsonSyndrome | |||||||
| Definition | Rothmund-Thomson syndrome | ||||||
| Short | Rothmund-Thomson syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 98. Subject.noGeneticSyndromeWho2020.wernerSyndrome | |||||||
| Definition | Werner syndrome | ||||||
| Short | Werner syndrome | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 100. Subject.noGeneticSyndromeWho2020.retinoblastoma | |||||||
| Definition | Retinoblastoma | ||||||
| Short | Retinoblastoma | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 102. Subject.noGeneticSyndromeWho2020.pagetDisease | |||||||
| Definition | Paget disease | ||||||
| Short | Paget disease | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 104. Subject.noGeneticSyndromeWho2020.otherSyndromes | |||||||
| Definition | Other Genetic syndrome WHO 2020 | ||||||
| Short | Other Genetic syndrome WHO 2020 | ||||||
| Control | 1..1 | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 106. Subject.occurrenceOfOtherCancer | |||||||
| Definition | Occurrence of other cancer | ||||||
| Short | Occurrence of other cancer | ||||||
| Comments | Children (and subchildren) of Neoplasm and/or hamartoma - 4266186 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 108. Subject.previousCancerTreatment | |||||||
| Definition | Previous cancer treatment | ||||||
| Short | Previous cancer treatment | ||||||
| Comments | Chemotherapy - 4273629 Radiation oncology- 4170755 Surgery - 4121697 Comprehensive medication therapy review - 42535584 Immunological therapy - 4295112 | ||||||
| Control | 1..1 | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
IG © 2022+ IDEA4RC Project. Package hl7.eu.fhir.idea4rc#0.1.0 based on FHIR 4.0.1. Generated 2024-11-12
Links: Table of Contents |
QA Report
The IDEA4RC project has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 101057048.
